
United States · Pharmaceuticals startup
Cabinet Health is a sustainable medicine company dedicated to eliminating single-use plastic from over-the-counter medications.
Funding reportedLast round: Undisclosed round
Cabinet Health is a sustainable medicine company dedicated to eliminating single-use plastic from over-the-counter medications.
They focus on developing compostable materials for medicine packaging, with profits directed towards enhancing healthcare quality and environmental health. The company operates as a climate-optimist venture, emphasizing product innovation and partnerships. Cabinet Health offers an at-home care platform that includes medication management and remote monitoring of vital signs. Their telemedicine services connect patients with healthcare professionals for personalized care through video consultations. They also assist with prescription transfers to their online platform, ensuring seamless medication management. Their product line features compostable medicine packaging and previously included refillable glass medicine bottles. The company targets individuals seeking sustainable healthcare solutions and those preferring at-home medical services.
Funding, as reported
Cabinet Health filed one raise, $218K in all. Filings say how much was sold and to how many investors; they never name the investors.
What they build
Known for
health careconsumersrecyclable glass bottlespharmaceutical sustainabilitysustainable pharmacy innovationrecyclable packaginginformation technology & servicesbiomaterial packagingplastic wastesustainable medicinecompostable poucheseco-conscious pharmaceutical packagingenvironmental serviceshospital & health caresustainabilitymedical
Built with from their website
Google Tag ManagerFramerKlaviyoGoogle WorkspaceViewport MetaGoogle AnalyticsHTTP/3GoDaddy DomainsGoogle Analytics 4Amazon AWS
Apple Business ManagerGoogle MeetPriority HintsReactTrustpilotHSTSAWS CloudCisco TelePresence Management Suite
Add your raise, your deck and your story, and put Cabinet Health in front of investors. Or tell us what we have wrong.